Results 61 to 70 of about 41,247 (202)

Chimpanzee Adenovirus Vector Ebola Vaccine

New England Journal of Medicine, 2017
The unprecedented 2014 epidemic of Ebola virus disease (EVD) prompted an international response to accelerate the availability of a preventive vaccine. A replication-defective recombinant chimpanzee adenovirus type 3-vectored ebolavirus vaccine (cAd3-EBO), encoding the glycoprotein from Zaire and Sudan species, that offers protection in the nonhuman ...
Julie E, Ledgerwood, Adam D, DeZure, Daphne A, Stanley, Emily E, Coates, Laura, Novik, Mary E, Enama, Nina M, Berkowitz, Zonghui, Hu, Gyan, Joshi, Aurélie, Ploquin, Sandra, Sitar, Ingelise J, Gordon, Sarah A, Plummer, LaSonji A, Holman, Cynthia S, Hendel, Galina, Yamshchikov, Francois, Roman, Alfredo, Nicosia, Stefano, Colloca, Riccardo, Cortese, Robert T, Bailer, Richard M, Schwartz, Mario, Roederer, John R, Mascola, Richard A, Koup, Nancy J, Sullivan, Barney S, Graham   +26 more
openaire   +2 more sources

Prescription for the People: An Activist\u27s Guide to Making Medicine Affordable for All [PDF]

, 2017
[Excerpt] Because every cure starts with an accurate diagnosis, in this book I explain how and why the current medicines system is dysfunctional and corrupt.
Quigley, Fran
core   +1 more source

Reimagining WHO: Leadership and Action for a New Director-General [PDF]

, 2017
Three candidates to be the next WHO Director-General remain: Tedros Adhanom Ghebreyesus, David Nabarro, and Sania Nishtar. The World Health Assembly’s ultimate choice will lead an Organization facing daunting internal and external challenges, from its ...
Friedman, Eric A., Gostin, Lawrence O.
core   +2 more sources

Infection Risk From Humans and Animals in the Anatomy Laboratory: A Scoping Review

Clinical Anatomy, Volume 39, Issue 3, Page 346-367, April 2026.
ABSTRACT Whole‐body dissection is a cornerstone of anatomy education. During and following the COVID‐19 pandemic, exposure to infectious agents and other risks of dissection were highlighted. To identify potential risks, one must have the data outlining these risks in specific situations.
Margaret A. McNulty, Elizabeth R. Agosto
wiley   +1 more source

Willingness-to-pay for a hypothetical Ebola vaccine in Indonesia: A cross-sectional study in Aceh [version 3; peer review: 3 approved, 1 not approved]

F1000Research, 2023
Background: Some Ebola vaccines have been developed and tested in phase III clinical trials. However, assessment of whether public have willingness to purchase or not, especially in unaffected areas, is lacking.
Samsul Anwar, Mudatsir Mudatsir, Amanda Yufika, Jonny Karunia Fajar, Salwiyadi Salwiyadi, Muhammad N. Ferdian, Roully Azhars, Harapan Harapan, Aga S. Imanda, Arya U. Timur, Darul Ilham, Ricky Yordani, Juwita Sahputri, Yogambigai Rajamoorthy, Setia Pramana, Kurnia F. Jamil, Abram L. Wagner   +16 more
doaj   +1 more source

Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir

British Journal of Pharmacology, Volume 183, Issue 7, Page 1578-1601, April 2026.
Background and Purpose Human adenovirus (HAdV) causes respiratory or gastrointestinal tract infections depending on the virus subtype. While HAdV infections are generally self‐limiting in immunocompetent people, they can result in significant morbidity and mortality in immunocompromised adults and children.
Mohamed Zamzamy, Sophie Post, Wing Hang Ip, Elin Hahlin, Sebastian Kühn, Andrea Pirosu, Christian Conze, Martin Baumdick, Hamburg Intestinal Study Group, Madeleine J. Bunders, Britta F. Zecher, Angelique Hoelzemer, Stephan Linder, Niklas Arnberg, Thomas Dobner, Marcus Altfeld, Sebastian Schloer   +16 more
wiley   +1 more source

Molecular characterization of Ebola virus, immune response, and therapeutic challenges: a narrative review

Egyptian Journal of Medical Human Genetics
The Ebola virus (EBOV) remains a major public health challenge due to its complex structure and the lack of appropriate and effective vaccines and therapies.
Martin Ndayambaje, Callixte Yadufashije, Thierry Habyarimana, Theogene Niyonsaba, Hicham Wahnou, Patrick Gad Iradukunda, Cedrick Izere, Olivier Uwishema, Pacifique Ndishimye, Mounia Oudghiri   +9 more
doaj   +1 more source

The Ebola Vaccine, Iatrogenic Injuries, and Legal Liability. [PDF]

PLoS Medicine, 2015
Amir Attaran and Kumanan Wilson propose a compensation system for vaccine injuries, based on no-fault principles, to ensure that recipients of Ebola vaccines are fairly compensated in cases of iatrogenic harm.
Amir Attaran, Kumanan Wilson
doaj   +1 more source

Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection

Frontiers in Immunology, 2021
Ebola viruses are enveloped, single-stranded RNA viruses belonging to the Filoviridae family and can cause Ebola virus disease (EVD), a serious haemorrhagic illness with up to 90% mortality.
Stephanie Longet, Jack Mellors, Miles W. Carroll, Miles W. Carroll, Tom Tipton   +4 more
doaj   +1 more source

Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assay. [PDF]

, 2011
Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) emerged as the causal agent of an endemic atypical pneumonia, infecting thousands of people worldwide.
Agudelo, Juliet, Amberg, Sean M, Chen, Yen Ting, Craik, Charles S, Goetz, David H, Hansell, Elizabeth, Lu, Kai, McKerrow, James, Roush, William R, Simmons, Graham, Zhou, Yanchen   +10 more
core   +1 more source